(Madeleine Hubbard) The U.S. Food and Drug Administration is no longer authorizing the monoclonal antibody treatment sotrovimab in 10 states and territories due to questions about its effectiveness against the BA.2 Omicron subvariant.
An Agent for Consciousness Evolution
(Madeleine Hubbard) The U.S. Food and Drug Administration is no longer authorizing the monoclonal antibody treatment sotrovimab in 10 states and territories due to questions about its effectiveness against the BA.2 Omicron subvariant.